Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: NCAPH promotes glucose metabolism reprogramming and cell stemness in ovarian cancer cells through the MEK/ERK/PD-L1 pathway

Fig. 3

NCAPH silencing inhibited glucose metabolism reprogramming in ovarian cancer cells. A The ECAR level was measured using the Seahorse XF Glycolytic Rate Assay Kit. B The OCR level was assessed using the Seahorse XF cell Mito Stress Test Kit. C Lactate production was quantified using lactate assay kit. D Glucose consumption was determined using glucose assay kit. E The expression levels of glycolysis-related proteins were analyzed by Western blot. All experiments were performed in triplicate.**P < 0.01 and ***P < 0.001

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us